Education

Biography

Dr. Costas Fourtounas is an Associate Professor of Internal Medicine-Nephrology in the Faculty of Medicine of the School of Health Sciences of the University of Thessaly in Larissa Greece. He received his medical degree from the Medical School of the Aristotelian University in Thessaloniki. He completed his fellowship training in Nephrology in Athens Greece and had extra training in UK and USA. His main interests include renal transplatation and dialysis (hemodialysis, peritoneal dialysis). He has published more than 130 papers in national and international peer-reviewed medical journals and has contributed with chapters in more than 10 medical books. He has been an editorial board member of 40 International Journals and has served as a reviewer for more than 80 medical journals.

Research Interest

1. Renal Transplantation
2. Hemodialysis
3. Peritoneal Dialysis
4. Diabetic Nephropathy
5. Renovascular Hypertension
6. Renal Anemia
7. Renal Osteodystrophy
   

Scientific activities

Employment History

Professional Activities

1. Hellenic Society of Nephrology
2. European Dialysis and Transplant Association (EDTA/ERA).
3. International Society of Nephrology (ISN).
4. American Society of Nephrology (ASN)
5. European Society of Artificial Organs (ESAO).
6. International Society of Peritoneal Dialysis (ISPD)
7. International Society of Blood Purification (ISBP).
8. International Society of Hemodialysis (ISHD).
9. International Society of Geriatric Nephrology and Urology (ISGNU)
10. National Kidney Foundation USA (NFK)
    

Publications

1. B. Agroyannis, A. Dalamangas, H. Tzanatos, I. Konstadinidou, C. Fourtounas, I. Kopelias, G. Rammos, D. Koutsikos. Relationship between echinocytosis and erythrocyte sedimentation rate (ESR) in hemodialysis.  Int J Artif Organs 1993, 16: 855-856.
2. B. Agroyannis, H. Tzanatos, K. Chondros, C. Fourtounas, I. Kopelias, G. Bougatsos, S. Voudiclaris, D. Koutsikos. Evaluation of blood ammonia alterations in uremic patients under hemodialysis and CAPD. Int J Artif Organs 1994; 17: 307-308.
3. B. Agroyannis, D. Mourikis, H. Tzanatos, C. Chondros, I. Kopelias, C. Fourtounas, D. Koutsikos, L. Vlachos. Renal vein ammonia concentration in unilateral renal artery stenosis and hypertension. Nephrol Dial Transplant 1994; 9: 1699-1700.
4. B. Agroyannis, A. Dalamangas, H. Tzanatos, C. Fourtounas, I. Kopelias, I. Konstadinidou, D. Koutsikos. Are alterations of protein 4.1 involved in the echinocytic transformation of red blood cells. Blood 1994; 84: 1685.
5. B. Agroyannis, A. Dalamangas, K. Dardoufas, Κ. Fortoynas, G. Salloum, E. Stringou, H. Tzanatos, D. Koutsikos, I. Papadimitriou. Serum transferrin and ceruloplasmin in patients with cancer of the gastrointestinal and other systems.Anticancer Res. 1994, 14: 2201-223.
6. C. Fourtounas, D. Kavadias, J. Tsouchnikas, K. Barboutis. Iron administration during erythropoietin therapy in hemodialysis patients.  Int J Artif Organs 1994, 17: 670.
7. C. Fourtounas, D. Kavadias, J. Tsouchnikas, K.. Barboutis. Iron deficiency during erythropoietin therapy in hemodialysis patients. Nephrol Dial Transplant 1994, 9: 735-736.
8. B. Agroyannis, A. Dalamangas, I. Kopelias, H. Tzanatos, C. Fourtounas, G. Bougatsos, S. Voudiclaris, D. Koutsikos. Caution in the interpretation of erythrocyte sedimentation rate in hemodialysis and CAPD patients. Nephrol Dial Transplant 1994; 9: 734-735.
9. D. Koutsikos, C. Fourtounas, A. Kapetanaki, A. Dalamangas, H. Tzanatos, B. Agroyannis, I. Kopelias, B. Bosiolis, G. Rammos, O. Bovoleti, G. Sammoul, M. Darema. A cross-over study of a new molecular weight heparin (Logiparin) in hemodialysis. Int J Artif Organs 1996 : 19: 467-471.
10. D. Koutsikos, C. Fourtounas, A. Kapetanaki, H. Tzanatos, B. Agroyannis, I. Kopelias, O. Bovoleti, B. Bosiolis. Hyperthyroidism in hemodialysis patients: report on a case and review of the literature. Nephrol Dial Transplant 1995,10:1765-1767.
11. B. Agroyannis, A. Dalamangas, H. Tzanatos, C. Fourtounas, I. Kopelias, D. Koutsikos. Relation between spiculated red cells and platelets in uraemic patients. Br J Haematology 1995, 89: 686-687.
12. D. Koutsikos, C. Fourtounas, A. Kapetanaki, B. Agroyannis, G. Rammos, I. Kopelias, B. Bosiolis, O. Bovoleti,  M. Darema,  G. Salloum. Oral glucose tolerance test after high dose I.V. biotin administration in normoglycemic hemodialysis patients. Renal Failure 1996, 18(1): 131-137.
13. D. Koutsikos, C. Fourtounas, B. Agroyannis, H. Tzanatos, I. Kopelias. Glucose metabolism in normoglucemic hemodialysis patients: A possible role for biotin?  Nephrol Dial Transplant 1995, 10:1256-1257
14. B. Agroyannis, A. Dalamangas, H. Tzanatos, C. Fourtounas, I. Kopelias, V. Bosiolis, O. Bovoleti, D. Koutsikos. Effect of acetate and erythropoietin on fetal hemoglobin in haemodialysed uremic patients. Blood 1995, 85: 3765-3766.
15. B. Agroyannis, A. Dalamangas, H. Tzanatos, C. Fourtounas, I. Kopelias, D. Koutsikos. Reply by the authors in: Reduction of echinocytes post dialysis. Nephrol Dial Transplant 1995, 5: 716-717
16. B. Agroyannis, H. Tzanatos, I. Kopelias, C. Fourtounas, D. Koutsikos. Renal ammoniagenesis and tubulointerstitial injury in hypertension.  Nephrol Dial Transplant 1995; 12: 2372-2373.
17. H. Tzanatos, C. Fourtounas, B. Agroyannis, K. Chondros, A. Dalamangas, B. Bosiolis, I. Kopelias, D. Koutsikos. Alterations of plasma Lipoprotein (a) concentration. Are they arising from the hemodialysis procedure?  Nephrol Dial Transplant 1996;11:1491-1492.
18. B. Agroyannis, A. Dalamangas, H. Tzanatos, C. Fourtounas, I. Kopelias, D. Koutsikos. Echinocytic transformation and aggregation of uremic patients red cells. J Appl Physiol 1995; 80: 711-712.
19. C. Fourtounas, D. Koutsikos, A. Dalamangas, A. Kapetanaki, M. Kostoglou, B. Agroyannis, H. Tzanatos, I. Kopelias, B. Bosiolis. Supervised intradialytic oral iron administration during erythropoietin therapy.  Nephrol Dial Transplant 1996; 11:1485-1486
20. B. Agroyannis, A. Dalamangas, H. Tzanatou, L. Soubassi, C. Fourtounas, I. Kopelias, O. Bovoleti, B. Bosiolis, D. Koutsikos. Alterations in echinocyte transformation and erythrocyte sedimentation rate during hemodialysis. Artif Organs 1997;21: 327-330
21. D. Kavadias, C. Fourtounas, I. Tsouchnikas, K. Barboutis. L-carnitine and erythropoietin requirements in hemodialysis patients.  Am J Kidney Dis 1996;28: 156
22. A. Chrysicopoulos, D. Koutsikos, A. Kapetanaki, B. Agroyannis, H. Tzanatos, G. Rammos, C. Fourtounas, I. Kopelias, B. Bossiolis, M. Darema, P. Zourlas. Evaluation of the Hypothalamic-pituitary axis in uremic males using dynamic tests. The possible role of testicular inhibin: A preliminary report. Renal Failure, 1996, 18(6): 911-921.
23. C. Fourtounas, H. Tzanatos, Ch. Fourtounas, I. Kopelias, B. Agroyannis. Androgens, erythropoietin, iron status and lipoprotein(a) in hemodialysis patients.  Am J Kidney Dis 1997; 30: 935-936 
24. B.Agroyannis, H.Tzanatos, C. Fourtounas, L. Soubassi, I. Kopelias, D. Koutsikos. Is echinocytic transformation of erythrocytes related to lipid peroxidation in hemodialysed uraemic patients ?  Clin Chim Acta 1997, 261 :185-187
25. B. Agroyannis, H. Tzanatos, C. Fourtounas, I. Kopelias, S. Katsoudas, K. Chondros. Arterio-venous difference of blood ammonia in uremic patients under hemodialysis. Artif Organs 1998,22 : 703-705
26. B. Agroyannis, C. Fourtounas, D.Mourikis, H Tzanatos, I. Kopelias. Management of claudication and hypertension by stent implantation in a renal transplant recipient. J Hum Hypertension 1998;12: 417-418
27. B.Agroyannis, D.Mouriklis, I.Kopelias, H. Tzanatos, L. Soubassi, C. Fourtounas. Ammonia concentration in blood of renal veins in unilateral renal artery stenosis and hypertension.  Q J Med 1998;91: 367-369
28. B.Agroyannis, H.Tzanatos, C. Fourtounas, I.  Kopelias. Telematics application for home hemodialysis. Kidney Int 1999;55: 338-340
29. B. Agroyannis, C. Fourtounas, H. Tzanatos, I.   Kopelias. Can telemedicine contribute to the expansion of home hemodialysis?  Nephrol Dial Transplant 1999;14 :251-252
30. B. Agroyannis, D. Mourikis, C. Fourtounas, H. Tzanatos, I. Kopelias,  A. Chatzioannou, P. Dimakakos. Ringed Gore-tex for hemodialysis access. Nephrol Dial Transplant 1999;14: 2520-1
31. B. Agroyannis,  C. Fourtounas, G. Romagnoli, M. Skiadas, C. Tsavdaris,C. Chassomeris, H. Tzanatos, I. Kopelias,  D. Lymberopoulos, J. Psarras. Telemedicine technology and applications for home hemodialysis. Int J Artif Organs 1999;22: 679-683
32. B. Agroyannis,  C. Fourtounas, G. Romagnoli, M. Skiadas, C. Tsavdaris, C. Chassomeris, H. Tzanatos, I. Kopelias, D. Lymberopoulos, J. Psarras. Telematics service for home and satellite hemodialysis .Home Hemodial Int 1999;3: 61-64
33. H. Tzanatos, B. Agroyannis, K. Chondros, A. Kapetanaki, C. Fourtounas, L. Soubassi, I. Kopelias. Cytokine release and serum lipoprotein(a) alterations during hemodialysis. Artif Organs 2000;24: 329-333.
34. B Agroyannis, C. Fourtounas, D. Mourikis, H. Tzanatos, I. Kopelias, A. Chatzioannou, P. Dimakakos. Disorders of angioaccess in an uremic patient with short bowel.  Dial&Transplant 2001;30: 299-303.
35. C. Fourtounas, I. Kopelias, G. Dimitriadis, .B Agroyannis. The impact of dialyzers on the anaemia of haemodialysis patients. Nephrol Dial Transplant 2001;16: 1077-78.
36. B.Agroyannis, I. Kopelias, C. Fourtounas, A.Paraskevopoulos, H.Tzanatos, A. Dalamangas, E.Mallas.Relation betweeen echinocytosis and erythrocyte calcium content in hemodialysed uremic patients. Artif Organs 2001;25: 486-490.
37. C. Fourtounas , I. Kopelias, G.Dimitriadis, A. Paraskevopoulos, B. Agroyannis. Severe metabolic acidosis during haemodialysis. A rare, but life-threatening complication. Nephrol Dial Transplant 2001;16: 2416-2417.
38. C. FOURTOUNAS. Evidence based or stock market driven nephrology. Nephrol Dial Transplant 2002;17: 690-691.
39. C. FOURTOUNAS. Invited comment in:  Recombinant human erythropoietin is effective in cancer related anaemia, but is it cost effective? Drugs & Therapy Perspectives 2001;17: 8-12.
40. B.Agroyannis, C.Fourtounas, I.Kopelias, A. Paraske-Vopoulos, G.Bougatsos, S.Katsoudas, H.Tzanatos, A.Tsomi, S. Voudiclari. Changes in erythrocytes Ca++, K+, Mg++ in uremic patients on CAPD. Perit Dial Int 2002;22: 269-272
41. B.Agroyannis, A. Paraskevopoulos, C. Fourtounas,  H. Tzanatos, A. Tsomi, D. Vlahakos, A. Dalamangas. Effect of L-Carnitine on the calcium content of erythrocytes of uremic patients on hemodialysis.  Dial &Transplant 2002;31: 106-109.
42. C. Fourtounas, V. Panteris, D. Valis. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis 2002;39: 660.
43. B.Agroyannis, C. Fourtounas, H. Tzanatos,  A. Dalamangas, D.Vlahakos.  Relationship between interdialytic weight gain and acid-base status in hemodialysis by bicarbonate. Artif Organs 2002; 26:385-387.
44. B. Agroyannis, C. Fourtounas, H. Tzanatos, D. Vlahakos. Changes in pH, H+, and K+  in patients undergoing hemodialysis with bicarbonate dialysate. Dial &Transplant 2002;31: 253-256      
45. C. Fourtounas , I. Kopelias, D. Kyriaki, B. Agroyannis. Increased cyclosporin levels after nisoldipine administration in a renal transplant recipient. Transplant Int 2002; 15: 586-588.
46. M. Skiadas, B. Agroyannis, E. Carson , D. Cramp , C. Fourtounas, A. Darnige, A.Morgan, D. Murley,H. Tsavdaris, C.Hassomeris, C. Skouras. Design, implementation and preliminary evaluation of a telemedicine system for home haemodialysis.  J Telemed Telecare 2002; 8: 157-64
47. B. Agroyannis, C. Fourtounas, H. Tzanatos, A. Kapetanaki, A. Dalamangas, D. Vlahakos. Pre- HD dilution acidosis, without post-HD contraction alkalosis in uremic patients. Int J Artif Organs 2003;26: 135-138 .
48. B.Agroyannis, C. Fourtounas, H. Tzanatos, A. Kapetanaki, M. Skiadas, A. Dalamangas, D. Vlahakos. Changes of apparent bicarbonate space (ABS) in uremic patients undergoing hemodialysis Dial & Transplant 2003;32: 686-689
49. C. Fourtounas, M. Marangos, P. Kalliakmani, E. Savidaki, Ds Goumenos, J.G. Vlachojannis. Treatment of peritoneal dialysis related fungal peritonitis with caspofungin plus amphotericin B combination therapy. Nephrol Dial Transplant 2006;21: 236-237
50. D.N. Karakitsos, Ap. Patrianakos, A. Paraskevopoulos, Fi. Parthenakis, N. Tzenakis, C. Fourtounas, E.K. Daphnis, P.E.Vardas. Impedance cardiography derived cardiac output in haemodialysis patients: a study of reproducibility and comparison with echocardiography. Int J Artif Organs 2006; 29: 564-572
51. C. Fourtounas, I. Kopelias, A. Paraskevopoulos, G. Dimitriadis, B. Agroyannis. Causes of impaired delivery of haemodialysis prescription.  Artif Organs 2006; 30: 878-881
52. C. Fourtounas, E. Savidaki, P, Dousdampanis, A. Hardalias, P. Kalliakmani, E. Papachristou, A. Drakopoulos, Ds Goumenos, Jg. Vlachojannis Peritonitis during the first year after commencement of peritoneal dialysis has an impact on technique survival and patient morbidity. Adv Perit Dial 2006; 22: 50-54.
53. C. Fourtounas, E. Savidaki, P, Dousdampanis  M. Roumelioti, A. Hardalias, P. Kalliakmani, E. Papachristou, A. Drakopoulos, Ds Goumenos, Jg. Vlachojannis Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate and bicarbonate buffered PD solutions. Adv Perit Dial 2006; 22: 187-191
54. Jc Maroulis, C. Fourtounas, Jg Vlachogannis, N. Siasos, D. Karavias, D. Chartoumpekis, I. Habaios. Calciphylaxis: a complication of end-stage renal disease improved by parathyroidectomy.Hormones - Int J Endocrol 2006; 5: 210-213.
55. D. Karakitsos, A.P. Patrianakos, F.I. Parthenakis, N. Malliaraki, D. Nikitovic, J. Kyriazis, A. Karabinis, J.W. Groothoff, E. De Groot, C. Fourtounas, E. Daphnis, P.E. Vardas. Altered proximal aortic stiffness and endothelin plasma levels in diabetic patients with end-stage renal disease. ASAIO J 2007; 53: 343-350
56. C. Fourtounas, P. Dousdampanis, A. Hardalias, E. Liatsikos, Jg Vlachojannis. Eosinophilic peritonitis following air entrapment during peritoneoscopic insertion of peritoneal dialysis catheters. Semin Dial 2008; 21: 180-182
57. A. Panagopoulou, A. Hardalias, S. Berati, C. Fourtounas. Psychosocial issues and quality of life in patients on renal replacement therapy. Saudi J Kidney Dis Transpl 2009; 20: 212-218
58. C. Fourtounas, A. Spyridonidis, P. Dousdampanis, E. Savidaki, P. Kalliakmani, E. Papachristou, D. Goumenos, Jg. Vlachojannis. Microchimerism in Peripheral Blood and Urine in Renal Transplant Recipients: Preliminary Results. Transplant Proc 2008; 40: 3434-
59. C. Fourtounas , A. Hardalias, P. Dousdampanis, V. Papachri-Stopoulos, E. Savidaki,  Jg Vlachojannis. Sodium removal in Peritoneal Dialysis: The role of icodextrin and PD modalities. Adv Perit Dial 2008; 24: 27-31
60. C. FOURTOUNAS. Pharmacodynamics of unfractionated heparin during and after a hemodialysis session: The impact of the administered dose.  Am J Kidney Dis 2008; 52: 805-806
61. C. Fourtounas, Jg Vlachojannis. PD underutilization in Europe: A call to action. Nephrol Dial Transplant 2008; 23: 3365-3366.
62. C. Fourtounas, Jg. Vlachojannis. Effect of clopidogrel on arteriovenous fistulas for dialysis. JAMA 2008; 300: 1648
63. C. Fourtounas, A. Mouzaki, Jg Vlachojannis. Desensitization during renal transplantation. N Engl J Med 2008; 359:    
64. C. Fourtounas, Jg. Vlachojannis. Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients.  Am J Clin Nutr 2009; 89:
65. C. Fourtounas. Hepatitis C and and anaemia in long-term maintenance haemodialysis patients. Nephrology (Carlton) 2009; 14: 137
66. T. Chiras, Ed Papadakis, A. Katopodi, E. Chatzianesti, C. Fourtounas, S. Papakonstantinou, I. Theodoropulos, A. Dakouras, N. Zerefos, D. Valis, H. Tzanatos-Exarchou. Platelet GR III A polymorphism HPA-1 (PLA1/2) is associated with hypertension as the primary cause for end-stage renal disease in hemodialysis patients from Greece. In Vivo 2009; 23: 177-181 
67. C. Fourtounas, P. Dousdampanis, A. Hardalias, Jg Vlachojannis. Peritoneoscopic reinsertion of a peritoneal dialysis catheter after fungal peritonitis: The advantage of visual information. Perit Dial Int 2009; 29: 580-581
68. C. Fourtounas, Jg Vlachojannis. Gingival hyperplasia and calcium channel blockers. J Clin Hypertens (Greenwich) 2009; 11: 111
69. C. Fourtounas, A. Hardalias, P. Dousdampanis, E. Savidaki, Jg Vlachojannis. Intermittent Peritoneal Dialysis (IPD): An old but still effective modality for severely disabled ESRD patients. Nephrol Dial Transplant 2009; 24: 3215-3218
70. C. Fourtounas, P. Dousdampanis, P. Sakellaraki, M. Rodi, T. Georgakopoulos, Jg Vlachojannis, A. Mouzaki. Regulatory T-cells in the periphery of stable renal transplant recipients receiving different combinations of immunosuppressive drugs Am J Nephrol 2010; 32: 1-9
71. C. FOURTOUNAS “Malignant” Intradialytic Hypertension: A severe form of intradialytic hypertension.  Am J Kidney Dis 2010; 56:
72. C. FOURTOUNAS. Potential bone effects of thiazolidinediones in diabetic dialysis patients. Semin Dial 2010; 23: 526
73. C. FOURTOUNAS. Methylene blue and peritoneal dialysis. Kidney Int 2011; 79: 136
74. C. FOURTOUNAS. Paracalcitol for reduction of albuminuria in diabetics. Lancet 2011; 377: 636
75. E. Savidaki, M. Koukoulaki, A. Benou, M. Roumeliotou, C. Fourtounas, P. Kalliakmani, E. Papachristou, Jg. Vlachojannis, D. Goumenos. Ezetimibe is effective in the treatment of persistent hyperlipidemia of renal allograft recipients. Clin Nephrol 2011; 75:107-112
76. C. FOURTOUNAS. Phosphorus Metabolism in Chronic Kidney Disease. Hippokratia 2011;15 (Suppl 1): 50-52
77. C. FOURTOUNAS. The present and the future of Peritoneal Dialysis Hippokratia 2011;15 (Suppl 2): 15-20
78. P. Dousdampanis, K. Trigka, C. Fourtounas, Jg Vlachojannis. Evolution of secondary hyperparathyroidism one year after successful renal transplantation. Hippokratia 2011;15 (Suppl 2): 30-32
79. C. Fourtounas, P. Dousdampanis, A. Hardalias, K. Trigka, Jg Vlachojannis. Peritoneoscopic insertion of peritoneal dialysis catheters by nephrologists.  A single centre preliminary experience. Hippokratia 2011; 15 (Suppl 2): 27-29
80. D. Alexopoulos, A. Panagiotou, I. Xanthopoulou , D. Komninakis, G. Kassimis, P. Davlouros, C. Fourtounas, D. Goumenos. Antiplatelet effects of prasugrel vs double clopidogrel in patients on hemodialysis and high on-treatment platelet reactivity.  J Thromb Haemost 2011; 9: 2379-85
81. K. Triga, P. Dousdampanis, C. Fourtounas. Delusional parasitosis: a rare cause of pruritus in hemodialysis patients Int J Artif Organs 2012; 35:400-403
82. D. Alexopoulos, I. Xanthopoulou, A. Panagiotou, D. Komninakis, N. Germanos, P. Goudas, E. Koutroulia, C. Fourtounas. Prevalence of inadequate platelet inhibition by clopidogrel in patients on hemodialysis.Am J Kidney Dis 2012; 59:469-471
83. C. FOURTOUNAS. Should all adult patients with diarrhoea associated HUS receive plasma exchange? Lancet 2012; 379:516
84. A. Mazarakis, G. Almpanis, N. Tragotsalou, D. Karnabatidis, C. Fourtounas. Is hypertension a manifestation of the nutcracker phenomenon/syndrome? Case report and brief review of the literature Hippokratia 2012;16: 187-189
85. C. FOURTOUNAS. Management of hypertension after kidney transplantation: a possible role for spiranolactone? J Hypertension 2012; 30: 830-831
86. C. FOURTOUNAS. Peritonitis rates with Biocompatible and Conventional Peritoneal Dialysis Solutions. Kidney Int 2012;81: 1150
87. P. Dousdampanis, K. Trigka, C. Fourtounas. Prevalence of anemia in patients with type II diabetes and mild to moderate chronic kidney disease and the impact of anti- RAS medications. Saudi J Kidney Dis Transpl  2014; 25: 552-557
88. C. FOURTOUNAS. Vitamin D therapy and cardiac function in chronic kidney disease.  JAMA 2012; 307: 2253
89. C. Fourtounas, I. Maroulis, D. Karnabatidis, A Hardalias, Jg Vlachojannis. Salvage of a totally occluded peritoneal dialysis catheter by laparoscopic milking. Sem Dial 2013; 26: E8-10 
90. P. Dousdampanis, K. Trigka, C. Fourtounas. Diagnosis and management of chronic kidney disease in the elderly: a field of ongoing debate. Aging & Disease 2012; 3: 360-372
91. C. FOURTOUNAS, P. DOUSDAMPANIS, A. HARDALIAS,  JG VLACHOJANNIS. Sodium Removal and Peritoneal Dialysis Modalities: No Differences with Optimal Prescription of Icodextrin. Artif Organs 2013; 37: E107-113
92. C. FOURTOUNAS, P. DOUSDAMPANIS. Kidney, Pancreas and Islet Transplant Options for Patients with Diabetic Nephropathy. J Diabetes Metab 2013 S9-001 doi: 10.4172/2155-6156.s9-001
93. C. FOURTOUNAS, A. PANAGIOTOU. Oral Antiplatelet Agents in Dialysis Patients: Friends or Foes? General Med  2013;1:3 doi: 10.4172/2327-5146.1000109
94. C. FOURTOUNAS.  Perceptions of gout (podagra) during the Byzantine era, with a special focus on a poem by Michael Psellus.  J Nephrol  2013; 26 (Suppl. 22):110 - 112  
95. C. FOURTOUNAS. Transplant options for patients with type 2 diabetes and chronic kidney disease. World J Transplant 2014;4: 102-108
96. P. DOUSDAMPANIS, K. TRIGA, G. VAGENAKIS, C. FOURTOUNAS. Thyroid and the Kidney: a Complex Interplay in Health and Disease. Int J Artif Organs 2014;37:1-12
97. P. DOUSDAMPANIS, K. TRIGA, C. FOURTOUNAS, JM BARGMAN. The role of testosterone in the pathogenesis, progression, prognosis and co-morbidity of men with chronic kidney disease. Ther Apher Dial 2014;18: 220-230
98. P. DOUSDAMPANIS, K. TRIGKA, C. FOURTOUNAS. Hypomagnesaemia, chronic kidney disease and cardiovascular mortality: pronounced association but unproven causation. Hemo Int 2014;18(4):730-39.
99. P. DOUSDAMPANIS, K. TRIGKA, CG MOUSSO, C. FOURTOUNAS. Hyperuricemia and chronic kidney disease: an enigma yet to be solved. Renal Failure 2014;36(9):1351-1359
100. P. DOUSDAMPANIS, K. TRIGKA, A. GIANNOPOULOS, C. FOURTOUNAS..  Pathogenesis and Management of Intradialytic Hypertension Curr Hypert Reviews 2014;10 (3):171-176